SI1551835T1 - Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba - Google Patents

Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba

Info

Publication number
SI1551835T1
SI1551835T1 SI200330715T SI200330715T SI1551835T1 SI 1551835 T1 SI1551835 T1 SI 1551835T1 SI 200330715 T SI200330715 T SI 200330715T SI 200330715 T SI200330715 T SI 200330715T SI 1551835 T1 SI1551835 T1 SI 1551835T1
Authority
SI
Slovenia
Prior art keywords
novel
preparation
diazabicycloalkane derivatives
diazabicycloalkane
derivatives
Prior art date
Application number
SI200330715T
Other languages
English (en)
Slovenian (sl)
Inventor
Dan Peters
Gunnar M Olsen
Elsebet Nielsen
Tino Jorgensen
Philip K Ahring
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Priority claimed from EP03798094A external-priority patent/EP1551835B1/en
Publication of SI1551835T1 publication Critical patent/SI1551835T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI200330715T 2002-09-30 2003-09-29 Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba SI1551835T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200201456 2002-09-30
DKPA200201738 2002-11-11
US42636802P 2002-11-15 2002-11-15
EP03798094A EP1551835B1 (en) 2002-09-30 2003-09-29 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
PCT/DK2003/000639 WO2004029053A1 (en) 2002-09-30 2003-09-29 Novel 1,4-diazabicycloalkane derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
SI1551835T1 true SI1551835T1 (sl) 2007-06-30

Family

ID=34828377

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330715T SI1551835T1 (sl) 2002-09-30 2003-09-29 Novi 1,4-diazabicikloalkanski derivati, njihova priprava in uporaba

Country Status (11)

Country Link
JP (1) JP4711391B2 (https=)
KR (1) KR20050062575A (https=)
CN (1) CN1326857C (https=)
BR (1) BR0314183A (https=)
IL (1) IL166821A (https=)
IS (1) IS7829A (https=)
MX (1) MXPA05003344A (https=)
NO (1) NO20052124L (https=)
PT (1) PT1551835E (https=)
RU (1) RU2323218C2 (https=)
SI (1) SI1551835T1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2368614C2 (ru) * 2004-02-04 2009-09-27 НьюроСёрч А/С Диазабициклические арильные производные в качестве модуляторов холинергических рецепторов
JO3019B1 (ar) * 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
US8158619B2 (en) * 2006-05-30 2012-04-17 Neurosearch A/S 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
US8492378B2 (en) 2006-08-03 2013-07-23 Takeda Pharmaceutical Company Limited GSK-3β inhibitor
KR20090110353A (ko) * 2007-02-15 2009-10-21 아젠터 디스커버리 리미티드 Ｍ３ 무스카린 수용체로서의 헤테로시클릭 유도체
AU2012338581B2 (en) 2011-11-18 2016-12-08 Nxera Pharma Uk Limited Muscarinic M1 receptor agonists
GB201404922D0 (en) 2014-03-19 2014-04-30 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201513743D0 (en) 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonists
GB201519352D0 (en) 2015-11-02 2015-12-16 Heptares Therapeutics Ltd Pharmaceutical compounds
EA201800367A1 (ru) * 2015-12-10 2019-02-28 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения болезни хантингтона
CN108752286B (zh) * 2016-09-18 2021-05-11 广西师范大学 1，2，8-氧代二氮杂环壬烷衍生物及其合成方法和应用
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819961D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226000A (en) * 1987-09-10 1991-06-25 Merck Sharp & Dohme Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
CZ282567B6 (cs) * 1993-12-29 1997-08-13 Pfizer Inc. Diazabicyklické sloučeniny a farmaceutické prostředky na jejich bázi
US5478939A (en) * 1994-07-20 1995-12-26 American Cyanamid Company (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
US6809107B1 (en) * 1999-07-09 2004-10-26 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic pyrrolidines and piperidines, and related compositions and methods
FR2804430B1 (fr) * 2000-01-28 2002-03-22 Sanofi Synthelabo Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
FR2809732B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
FR2809731B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
FR2832713B1 (fr) * 2001-11-23 2004-02-13 Sanofi Synthelabo Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
IL166821A0 (en) 2006-01-15
JP2006503062A (ja) 2006-01-26
IS7829A (is) 2005-04-28
NO20052124L (no) 2005-06-29
IL166821A (en) 2009-06-15
HK1081954A1 (en) 2006-05-26
KR20050062575A (ko) 2005-06-23
BR0314183A (pt) 2005-08-09
RU2005105048A (ru) 2005-11-20
NO20052124D0 (no) 2005-04-29
PT1551835E (pt) 2007-03-30
RU2323218C2 (ru) 2008-04-27
CN1326857C (zh) 2007-07-18
MXPA05003344A (es) 2005-11-23
CN1684965A (zh) 2005-10-19
JP4711391B2 (ja) 2011-06-29

Similar Documents

Publication Publication Date Title
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0401335A3 (en) Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
IL164627A0 (en) Novel biomaterials, their preparation and use
HRP20041157B1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
AU2003271734A1 (en) 7h-dibenzo(b,g)(1,5)dioxocin-5-one derivatives and use thereof
PL375309A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments